Patent application number | Description | Published |
20080213330 | Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons - A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent. | 09-04-2008 |
20080233188 | Stable Pharmaceutical Compositions Comprising a Pyrimidine - Sulfamide - The invention relates to stable pharmaceutical compositions comprising the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof. | 09-25-2008 |
20080279955 | Pharmaceutical microparticles - Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation. | 11-13-2008 |
20090137462 | PHARMACEUTICAL COMPOSITION COMPRISING CYCLIC SOMATOSTATIN ANALOGUES - The present invention describes parenteral pharmaceutical compositions comprising a somatostatin analogue and novel somatostatin analogues. | 05-28-2009 |
20100004274 | Stable pharmaceutical compositions comprising a pyrimidine-sulfamide - Stable pharmaceutical compositions include the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof: | 01-07-2010 |
20100029550 | ORGANIC COMPOUNDS - A pharmaceutical composition for parenteral administration of a somatostatin analogue salt of aspartate, e.g. mono- or diaspartate, lactate, succinate, e.g. mono- or disuccinate, acetate, glutamate, e.g. mono- or diglutamate or citrate and water forming a gelling depot system after injection in contact with the body fluid. | 02-04-2010 |
20100178344 | Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles - The present invention relates to improved microparticles comprising a somatostatin analogue, a process of making said microparticles and to pharmaceutical compositions comprising the same. | 07-15-2010 |
20100272809 | MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES - Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles. | 10-28-2010 |
20110301100 | Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons - A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent. | 12-08-2011 |
20120107408 | PHARMACEUTICAL MICROPARTICLES - Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation. | 05-03-2012 |
20120214749 | MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES - Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles. | 08-23-2012 |
20130116178 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYETHYLENE GLYCOL HAVING A MOLECULAR WEIGHT OF LESS THAN 600 DALTONS - A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent. | 05-09-2013 |
20130129798 | Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles - The present invention relates to improved microparticles comprising a somatostatin analogue, a process of making said microparticles and to pharmaceutical compositions comprising the same. | 05-23-2013 |
20130190336 | STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A PYRIMIDINE-SULFAMIDE - The invention relates to stable pharmaceutical compositions comprising the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof | 07-25-2013 |
20130236550 | PHARMACEUTICAL MICROPARTICLES - Microparticles consisting of (a) a matrix with a mixture of (a | 09-12-2013 |
20140235555 | Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons - A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Dalton's, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent. | 08-21-2014 |